Literature DB >> 7906209

Neuropsychopharmacologic challenge in biological psychiatry.

E F Coccaro1, R J Kavoussi.   

Abstract

Psychopharmacologic challenge procedures offer many useful features for biological psychiatry research. First, challenge procedures acutely stimulate neurotransmitter and (or) hormonal systems in the brain and offer the chance to assess the function, and (or) reserve, of the brain neurotransmitter/hormone system of relevance. Second, these paradigms often offer functional information about specific areas of the brain (e.g., limbic-hypothalamus). Regardless of these advantages, the power of these procedures is limited to the specificity of the agent and of the functional anatomy of the "circuit" that leads to the outcome measure, which, in turn, is linked to the stimulation by the acute pharmacologic challenge. We describe here the development of the psychopharmacologic challenge methodology and the strengths and weaknesses of this approach. Finally, the application of this paradigm in the study of various neuropsychiatric disorders will be reviewed and critiqued.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7906209

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  6 in total

Review 1.  Revisiting the serotonin-aggression relation in humans: a meta-analysis.

Authors:  Aaron A Duke; Laurent Bègue; Rob Bell; Tory Eisenlohr-Moul
Journal:  Psychol Bull       Date:  2013-02-04       Impact factor: 17.737

2.  5-HT3 receptor antagonism by ondansetron does not attenuate prolactin response to d-fenfluramine challenge in healthy human subjects.

Authors:  E F Coccaro; R J Kavoussi; T B Cooper; R Hauger
Journal:  Psychopharmacology (Berl)       Date:  1996-09       Impact factor: 4.530

Review 3.  Serotonergic function, two-mode models of self-regulation, and vulnerability to depression: what depression has in common with impulsive aggression.

Authors:  Charles S Carver; Sheri L Johnson; Jutta Joormann
Journal:  Psychol Bull       Date:  2008-11       Impact factor: 17.737

4.  Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects.

Authors:  Emil F Coccaro; Royce Lee; Richard J Kavoussi
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

5.  5-HT2a/2c receptor blockade by amesergide fully attenuates prolactin response to d-fenfluramine challenge in physically healthy human subjects.

Authors:  E F Coccaro; R J Kavoussi; M Oakes; T B Cooper; R Hauger
Journal:  Psychopharmacology (Berl)       Date:  1996-07       Impact factor: 4.530

6.  Studying the effects of dietary body weight-adjusted acute tryptophan depletion on punishment-related behavioral inhibition.

Authors:  Tilman J Gaber; Vita L S Dingerkus; Molly J Crockett; Sarah Bubenzer-Busch; Katrin Helmbold; Cristina L Sánchez; Brigitte Dahmen; Beate Herpertz-Dahlmann; Florian D Zepf
Journal:  Food Nutr Res       Date:  2015-08-11       Impact factor: 3.894

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.